After trials on two groups of volunteers, Russia’s Gamaleya Research Centre announced it has created the first vaccine against COVID-19. According to Russian Health Minister Mikhail Murashko, the first batch of the drug, known as "Sputnik-V", will be produced in 2 weeks and delivered for voluntary vaccination in Russian hospitals.
The vaccine is a two-component treatment based on the human adenovirus, which, according to scientists, makes people develop immunity to the virus for at least two years.
Russia has become the first country in the world to register a COVID-19 vaccine, which was dubbed Sputnik V. The vaccine was developed by the Gamaleya Institute and is currently undergoing phase III trials.
Last week, Russia became the first country in the world to register a COVID-19 vaccine, which was dubbed Sputnik V. The vaccine was developed by the Gamaleya Institute and is currently undergoing phase III trials.
Russia registered the world’s first Covid-19 vaccine, Sputnik V, developed by the Gamaleya Institute. Sputnik talked to Petros Arkumanis, a Greek doctor, to discuss why the Russian vaccine was developed faster than others, as well as whether it has certain characteristics that make it more effective than foreign vaccines.
The Russian health minister earlier dismissed allegations of ineffectiveness and potential dangers of the first vaccine protecting against COVID-19, alleging that such rumours are just a result of "certain competition" felt by foreign colleagues of the Russian researchers.
MOSCOW (Sputnik) - Russia is working with four partners in India on the production of its COVID-19 vaccine, the Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev said on Thursday.
According to a recent national survey by El Financiero, Mexicans' expectations that the coronavirus vaccine could soon be available rose from 27% to 36% between 11 July and 15 August.
BEIJING (Sputnik) - China's leading epidemiologist, Zhong Nanshan, has given high praise to the Russian vaccine against COVID-19 and has congratulated the country on completing the vaccine registration, the Russian Embassy in Beijing said on Thursday.
The British government restricted travel to Spain late last month and imposed a two-week quarantine on returning holidaymakers.
Last week, Russia registered the world’s first COVID-19 vaccine, developed by the Moscow-based Gamaleya Institute with support from the Russian Defence Ministry and the Direct Investment Fund (RDIF). According to RDIF CEO Kirill Dmitriev, the country has already received preliminary requests for one billion vaccine doses from over 20 countries.
Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev earlier revealed that Russia has already received preliminary requests for 1 billion doses of its vaccine against COVID-19 from over 20 countries.
Russia registered the world's first coronavirus vaccine, which it named Sputnik V last week. The vaccine was produced by the country's Gamaleya Microbiology Research Centre and entered Phase 3 of clinical trials on Wednesday.
Public Health England has been blamed for poorly handling the coronavirus pandemic because it failed to ramp up COVID testing early in the crisis, abandoning a programme of widespread contact tracing as the number of cases rose.
According to the World Health Organisation (WHO), the global coronavirus death toll has surpassed 767,000 people, with the number of cases worldwide exceeding 21.5 million.
Caracas has shown interest in the recently-approved Russian vaccine, Sputnik V. The vaccine will see a wide rollout in January 2021 at the earliest, and the timeframe for delivery to Venezuela is yet unclear.
Russia formally began production of the world’s first novel coronavirus vaccine, named the Sputnik V, this week. The vaccine, created by the Moscow-based Gamaleya Research Institute of Epidemiology and Microbiology, was fast-tracked for approval after proving capable of building up immunity against the virus in limited human testing.
On 11 August, Russia registered the world's first vaccine against COVID-19. The vaccine was produced by the Gamaleya Research Institute and was approved after several rounds of trials on volunteers.
Russia registered the world’s first COVID-19 vaccine, named Sputnik V, earlier this week. The Russian Ministry of Health has said that Sputnik V had undergone all necessary checks and proven to be capable of building immunity against the virus.
MOSCOW (Sputnik) - Russia has launched the production of the vaccine from COVID-19 developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology, the Russian Health Ministry said on Saturday.
Russia’s President Vladimir Putin announced the registration of the world's first vaccine against the coronavirus infection after having successfully undergone trials. The production of the drug has already kicked off, with the country expecting to make around 500 million doses in the first 12 months.
BANGKOK (Sputnik) - Thailand will carefully watch Russia's coronavirus vaccine rollout before deciding whether to recommend it for local use, the head of the National Vaccine Institute said Friday.